As a comparator HIV blood based self test patented by Atomo appears to have been tested in 2015&16 and approved in 2017 with funding and
influence from Gates Foundation , A 2 year clinical test period is not unusual for a medical diagnostic . IMO AXE bio chip is not in a
better position The complexity of the bio chipped and lack of any proof of concept evidence puts it in a different class to a RAT (see
generally ANN 16/4/2020 ATOMO & https://www.sofpromed.com/how-much-does-a-clinical-trial-cost )
As a comparator HIV blood based self test patented by Atomo...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $57.34M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 22.5¢ | $68.86K | 302.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 255150 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 80558 | 8 |
View Market Depth
| Last trade - 14.36pm 26/06/2025 (20 minute delay) ? |
| AXE (ASX) Chart |